GenomiCare Biotechnology joins the Roche Accelerator

Shanghai,June 8th, 2022 - GenomiCare Biotechnology (Shanghai) Co., Ltd. (hereinafter referred to as GenomiCare Biotechnology) announces acceptance by the Roche Accelerator. With the support from Roche Accelerator, GenomiCare Biotechnology will further devote...

read more

Highlights from ISPOR (Real World China)

GenomiCare’s sponsored ISPOR Webinar featured a cast of experts from Novartis, Roche, and AstraZeneca in a engaging  discussion about Real World Evidence in China. Key takeaways included: On the data, itself: Representativeness and Quality of data is paramount Overall...

read more

GenomiCare Is on List of 2020 Deloitte China Technology Fast 50 & China Rising Star

The 2020 China Technology Fast 50 & China Rising Star lists were officially published by the Beijing office of Deloitte on December 9 and reported by dozens of news outlets. GenomiCare is on list of the 2020 China Rising Star thanks to its “two-wheel-drive” business model, powerful translational cancer research, and flexible data solutions for clinical oncology drug development.

read more